The brokerage industry regulator cited gaps in surveillance, customer due diligence, and red-flag escalation across the ...

On July 21, 2025, the Financial Crimes Enforcement Network (FinCEN) announced its intention to postpone, for two years, the effective date of a final rule subjecting investment advisers to the ...

Two of the largest organizations representing investment advisers and asset managers are voicing support for a federal proposal to postpone new anti-money laundering requirements for RIAs, while ...

FinCEN has postponed the effective date of its AML/CFT rule for investment advisers until January 1, 2028, giving fund managers more time to prepare. The rule would require advisers to adopt bank-like ...

In financial institutions across the United States, there’s a reflex that’s become almost ritual. When a regulator walks in, or a board member asks whether the AML program is working, the answer is ...

Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid leukemia ...

The Treasury Department is postponing its investment advisor anti-money laundering rule by two years and plans to “revisit the scope” of the regulation. The Department’s Financial Crimes Enforcement ...

A recent study shows a regimen of low-dose homoharringtonine, cytarabine, and G-CSF (HAG) is an effective and promising treatment for pediatric patients with AML.

At a public hearing on July 31, 2012, Assistant Attorney General Lanny Breuer asserted that "financial institutions are often law enforcement's first line of defense" in the war against money ...

The U.S. Treasury Department has proposed taking a more central role in the enforcement of anti-money-laundering rules in a bid to overhaul a system for catching illicit transactions by drug ...

SEATTLE, WA / ACCESS Newswire / June 18, 2025 / Aptevo Therapeutics ("Aptevo") (Nasdaq:APVO), a clinical-stage biotechnology company developing novel bispecific immuno-oncology therapeutics based on ...

– The Steering Committee brings together distinguished clinical experts in AML from leading National Comprehensive Cancer Network Centers – SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today ...